Migraine care has the potential to improve greatly, with the development of new management guidelines, the introduction of new treatments and the use of evidence-based medicine to objectively rate and compare available therapies. These initiatives have allowed the production of these new MIPCA guidelines designed to improve migraine management in UK primary care. However, more initiatives are still needed, including:

• Better patient, physician, nurse and pharmacist education.

• The refinement of diagnostic procedures.

• Improved management of children and adolescents with migraine.

• The development of new acute and (in particular) prophylactic drugs.

• Specific guidelines for the use of complementary therapies.

• The development of new, patient-friendly headache diaries.

The guidelines discussed here will undoubtedly be refined over the coming years and we hope that international guidelines will also be developed in the near future.

http://www.medscape.com/viewarticle/446557_5